Bioventus Inc. (BVS) NASDAQ

$2.10 -0.10 (-4.54%)

Market Cap: $129.49M

As of 02/03/23 04:00 PM EST. Market closed.

(BVS)

Bioventus Inc. (BVS) NASDAQ

$2.10 -0.10 (-4.54%)

Market Cap: $129.49M

As of 02/03/23 04:00 PM EST. Market closed.

Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations For Active Healing from Bioventus include offerings for osteoarthritis, surgical and non-surgical bone healing. Built on a commitment to high quality standards, evidence-based medicine and ... read more

Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations For Active Healing from Bioventus include offerings for osteoarthritis, surgical and non-surgical bone healing. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$2.15
Previous Close
$2.20
Days Range
$2.05 - $2.20
52 week range
$1.65 - $15.10
Volume
657,110
Avg. Volume (30 days)
290,828
Market Cap
$129.49M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
61,664,158
Open
$2.15
Previous Close
$2.20
Days Range
$2.05 - $2.20
52 week range
$1.65 - $15.10
Volume
657,110
Avg. Volume (30 days)
290,828
Market Cap
$129.49M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
61,664,158

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BIOVENTUS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
D'Adamio AnthonySVP & General CounselApr 04, 2022 Sale$11.1916,016179,23840,132Apr 05, 2022, 09:16 PM
Nosenzo JohnChief Commercial OfficerApr 04, 2022 Sale$11.1265,963733,50283,932Apr 05, 2022, 09:14 PM
Pavesio AlessandraSVP & Chief Science OfficerApr 04, 2022 Sale$11.1732,997368,425148,309Apr 05, 2022, 09:09 PM
Pavesio AlessandraSVP & Chief Science OfficerFeb 14, 2022 Sale$11.994335,192119,830Feb 16, 2022, 06:29 PM
D'Adamio AnthonySVP & General CounselFeb 14, 2022 Sale$11.991,29415,51318,672Feb 15, 2022, 09:31 PM
Anglum Gregory O.SVP & CFOFeb 14, 2022 Sale$11.991,29415,51855,013Feb 15, 2022, 09:27 PM
Nosenzo JohnChief Commercial OfficerFeb 14, 2022 Sale$11.995346,40143,370Feb 15, 2022, 09:17 PM
Pavesio AlessandraSVP & CHIEF SCIENCE OFFICERFeb 10, 2022 Option Exercise$12.8873,915952,025118,793Feb 14, 2022, 08:43 PM
Nosenzo JohnCHIEF COMMERCIAL OFFICERFeb 10, 2022 Option Exercise$12.8824,205311,76042,434Feb 14, 2022, 08:41 PM
D'Adamio AnthonySVP & General CounselFeb 10, 2022 Option Exercise$12.886,59984,99515,566Feb 14, 2022, 08:37 PM
Anglum Gregory O.SVP & CFOFeb 10, 2022 Option Exercise$12.8819,674253,40151,907Feb 14, 2022, 08:35 PM
Reali Kenneth MichaelCHIEF EXECUTIVE OFFICERSep 09, 2021 Buy$14.811,80026,65811,175Sep 10, 2021, 09:22 AM
Anglum Gregory O.SVP & General CounselFeb 11, 2021 Buy$13.006,00078,0006,000Apr 05, 2021, 04:35 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
D'Adamio AnthonySVP & General Counsel04/04/2022179,238
Nosenzo JohnChief Commercial Officer04/04/2022733,502
Pavesio AlessandraSVP & Chief Science Officer04/04/2022368,425
Pavesio AlessandraSVP & Chief Science Officer02/14/20225,192
D'Adamio AnthonySVP & General Counsel02/14/202215,513
Anglum Gregory O.SVP & CFO02/14/202215,518
Nosenzo JohnChief Commercial Officer02/14/20226,401
Pavesio AlessandraSVP & CHIEF SCIENCE OFFICER02/10/2022952,025
Nosenzo JohnCHIEF COMMERCIAL OFFICER02/10/2022311,760
D'Adamio AnthonySVP & General Counsel02/10/202284,995
Anglum Gregory O.SVP & CFO02/10/2022253,401
Reali Kenneth MichaelCHIEF EXECUTIVE OFFICER09/09/202126,658
Anglum Gregory O.SVP & General Counsel02/11/202178,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
10/01/2022
07/02/2022
0.38%
1Q
10/01/2022
04/02/2022
1.20%
2Q
10/01/2022
12/31/2021
34.61%
3Q
10/01/2022
10/02/2021
46.37%
4Q
10/01/2022
07/03/2021
46.42%
5Q
10/01/2022
04/03/2021
46.44%
6Q
Load More

Period of Report: 10/01/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
07/02/2022
0.38%
1Q
04/02/2022
1.20%
2Q
12/31/2021
34.61%
3Q
10/02/2021
46.37%
4Q
07/03/2021
46.42%
5Q
04/03/2021
46.44%
6Q
Load More